Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study

详细信息    查看全文

• 作者：R. Salido-Vallejo ; I. Cuevas-Asencio ; G. Garnacho-Sucedo ; A. Gonzá ; lez-Menchen ; C. Alcá ; ntara-Reifs ; S. De la Corte-Sá ; nchez ; A. Vé ; lez and J.C. Moreno-Gimé ; nez
• 刊名：Journal of the European Academy of Dermatology and Venereology
• 出版年：2016
• 出版时间：July 2016
• 年：2016
• 卷：30
• 期：7
• 页码：1120-1124
• 全文大小：339K
• ISSN：1468-3083

文摘

Intralesional methotrexate (MTX–il) has been used as neoadjuvant therapy for keratoacanthoma but has only been utilized in a few isolated cases of cutaneous squamous cell carcinoma as neoadjuvant therapy (cSCC).